. .

 
Zuruecksetzen

Suchergebnis - Alexion Pharmaceuticals

Zeit Titel
23.08 09:08dpa-AFX: ALXN & Takeover Rumors, AMGN's JASMINE Blooms, CLSD Sees The Writing On The Wall
26.07 14:47dpa-AFX: Alexion Gets Positive Opinion From CHMP For SOLIRIS For Treatment Of NMOSD
26.07 14:10dpa-AFX: *ALEXION GETS POSITIVE CHMP OPINION FOR SOLIRIS FOR TREATMENT OF NMOSD
24.07 13:13dpa-AFX: Alexion Boosts FY19 Outlook
24.07 12:34dpa-AFX: *ALEXION Q2 GAAP EPS $2.04; NON-GAAP EPS $2.64
20.06 14:20dpa-AFX: *ALEXION PHARMA: FDA ACCEPTS SBLA FOR ULTOMIRIS UNDER PRIORITY REVIEW FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME
14.06 12:35dpa-AFX: *ALEXION PHARMA SAYS POSITIVE PHASE 3 EXTENSION DATA FOR ULTOMIRIS PRESENTED AT EHA CONGRESS
25.05 05:18dpa-AFX: Biotech Stocks Facing FDA Decision In June 2019
25.05 05:18dpa-AFX: Biotech Stocks Facing FDA Decision In June 2019
25.05 05:17dpa-AFX: Biotech Stocks Facing FDA Decision In June 2019
25.05 05:17dpa-AFX: Biotech Stocks Facing FDA Decision In June 2019
25.04 12:53dpa-AFX: Alexion Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates
25.04 12:53dpa-AFX: Alexion Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates
25.04 12:42dpa-AFX: *ALEXION Q1 NON-GAAP EPS $2.39, 42% INCREASE FROM PRIOR YEAR
25.04 12:42dpa-AFX: *ALEXION Q1 TOTAL REVENUES $1.14 BLN, UP 23% FROM PRIOR YEAR
25.04 12:35dpa-AFX: *ALEXION Q1 GAAP EPS $2.61, UP 135% FROM LAST YEAR
20.03 12:07dpa-AFX: *ALEXION AND ZEALAND PHARMA ANNOUNCE COLLABORATION TO DEVELOP PEPTIDE THERAPIES FOR COMPLEMENT-MEDIATED DISEASES
20.03 11:37dpa-AFX: *ALEXION TO PROVIDE AFFIBODY WITH UPFRONT PAYMENT OF $25 MLN, WITH POTENTIAL FOR MILESTONES OF UP TO $625 MLN
20.03 11:36dpa-AFX: *ALEXION AND AFFIBODY AB ANNOUNCE PARTNERSHIP TO CO-DEVELOP ABY-039
04.02 13:01dpa-AFX: Alexion Pharmaceuticals Q4 18 Earnings Conference Call At 8:00 AM ET

© 2000-2019 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen |
2019 vwd Vereinigte Wirtschaftsdienste GmbH